熔点	-3 ºC
水溶性	0.01 g/L (20 ºC)
沸点	295 ºC
闪点	130 ºC
密度	0.86
折射率	1.446-1.448

危险品标志	Xi
危险类别码	R36/37/38
安全说明书	S26;S36

来源	SDS样本
Sigma-Aldrich	浏览或下载
TCI	浏览或下载
Acros-Organics	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.Jessica L Heath et al.Pediatric blood & cancer, 61(10), 1874-1876 (2014-06-04) Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.Yasuhiro Oki et al.British journal of haematology, 163(5), 611-620 (2013-10-15) Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.Benjamin Boyerinas et al.Blood, 121(24), 4821-4831 (2013-04-17) Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.Nico Lachmann et al.Neoplasia (New York, N.Y.), 15(3), 239-248 (2013-03-13) A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.Emmanuel Griessinger et al.Stem cells translational medicine, 3(4), 520-529 (2014-02-05) Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.Dieter Hoelzer et al.Blood, 124(26), 3870-3879 (2014-11-02) Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist.Lior Soday et al.Cell reports, 27(6), 1920-1933 (2019-05-09) Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.Richard L Tower et al.Journal of pediatric hematology/oncology, 36(5), 353-361 (2014-03-13) Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.Luca Maurillo et al.American journal of hematology, 90(2), 125-131 (2014-11-08) Epigenetic action of decitabine (5-aza-2'-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C).Richard L Momparler et al.Leukemia research, 37(8), 980-984 (2013-05-11) Resident rounds. Part III: Neutrophilic eccrine hidradenitis in the setting of acute myelogenous leukemia treated with cytarabine.Darya Shlapak et al.Journal of drugs in dermatology : JDD, 12(2), 231-232 (2013-04-05) Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.Marko Kavcic et al.Cancer, 119(10), 1916-1923 (2013-02-26) Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure.Michael V Jaglal et al.Leukemia research, 38(4), 443-446 (2014-01-21) Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.Hiroaki Shimizu et al.Leukemia research, 37(11), 1477-1481 (2013-09-24) Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.Thomas Prebet et al.Leukemia research, 38(1), 29-33 (2013-08-21) Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia.Andrew M Brunner et al.American journal of hematology, 88(8), 642-646 (2013-04-27) Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2.Misaki Kawasoe et al.Experimental hematology, 41(7), 597-603 (2013-03-20) Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.Chinavenmeni S Velu et al.The Journal of clinical investigation, 124(1), 222-236 (2013-12-18) Organ Culture and Grafting of Choroid Plexus into the Ventricular CSF of Normal and Hydrocephalic HTx Rats.Conrad E Johanson et al.Journal of neuropathology and experimental neurology, 79(6), 626-640 (2020-05-18) Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron diseaseLim MA, et al. The Journal of Neuroscience, 32(3), 1123-1141 (2012) CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1.Xiaolin Wu et al.Journal of the American Heart Association, 9(9), e014920-e014920 (2020-05-01) Cutaneous inflammation differentially regulates the expression and function of Angiotensin-II types 1 and 2 receptors in rat primary sensory neurons.Sergio G Benitez et al.Journal of neurochemistry, 152(6), 675-696 (2019-08-07) Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.Jae-Ho Yoon et al.American journal of hematology, 88(12), 1074-1081 (2013-08-29) The effect of decreased-dose idarubicin for elderly patients with acute myeloid leukemia.Takashi Kobayashi et al.Japanese journal of clinical oncology, 43(10), 1047-1051 (2013-08-21) Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.J T Sandlund et al.Pediatric blood & cancer, 61(2), 360-362 (2013-08-01) HLA-partially matched cellular therapy (stem-cell microtransplantation) for acute myeloid leukaemia: description of four cases.Rafael Forés et al.British journal of haematology, 165(4), 580-581 (2014-03-29) Synaptic vesicle traffic is supported by transient actin filaments and regulated by PKA and NO.Nicolas Chenouard et al.Nature communications, 11(1), 5318-5318 (2020-10-23) Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.Dario Ferrero et al.Annals of hematology, 93(8), 1391-1400 (2014-04-08) Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.Eva Hoster et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(13), 1338-1346 (2014-04-02) Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.Steven E Coutre et al.British journal of haematology, 165(4), 497-503 (2014-02-18) Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.Diego Gomez-Nicola et al.Brain : a journal of neurology, 137(Pt 8), 2312-2328 (2014-06-20) CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.Ye Chen et al.The Journal of clinical investigation, 123(6), 2395-2407 (2013-05-17) [A man with neutropenic fever].J C Janneke Ham et al.Nederlands tijdschrift voor geneeskunde, 157(12), A5997-A5997 (2013-03-22) Transcriptional analysis of ORF amv133 of Amsacta moorei entomopoxvirus.Emine Ozsahin et al.Archives of virology, 159(10), 2541-2547 (2014-05-07) Blue toes and a new pair of shoes--challenges in diagnosis and treatment of acute myelogenous leukemia.Nataliya Mar et al.American journal of hematology, 88(12), 1090-1093 (2013-08-07) Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.Caroline Palmeira dos Santos et al.Journal of cancer research and clinical oncology, 140(6), 909-920 (2014-03-25) BMP4 is involved in the chemoresistance of myeloid leukemia cells through regulating autophagy-apoptosis balance.Xielan Zhao et al.Cancer investigation, 31(8), 555-562 (2013-09-21) Case records of the Massachusetts General Hospital. Case 7-2014. A 27-year-old man with diarrhea, fatigue, and eosinophilia.Amir T Fathi et al.The New England journal of medicine, 370(9), 861-872 (2014-02-28) An Improved Method for Differentiating Mouse Embryonic Stem Cells into Cerebellar Purkinje Neurons.Christopher J Alexander et al.Cerebellum (London, England), 18(3), 406-421 (2019-02-08) Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).R Willemze et al.Annals of hematology, 93(6), 965-975 (2014-04-01) Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord.Chang-Ching Yang et al.PloS one, 3(10), e3336-e3336 (2008-10-15) MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years.Andrés J M Ferreri et al.Neurology, 82(15), 1370-1373 (2014-03-19) Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program.Hernan Carol et al.Pediatric blood & cancer, 62(1), 65-71 (2014-09-10) The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma.Leo Rasche et al.Annals of hematology, 93(7), 1207-1214 (2014-02-15) Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.Wenjun Zhang et al.Medicine, 93(27), e134-e134 (2014-12-17) Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.David Martínez-Cuadrón et al.Annals of hematology, 93(1), 43-46 (2013-10-02) The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.Xing Shen et al.Cancer letters, 356(2 Pt B), 686-696 (2014-12-03) Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol.M Lowrie et al.The Veterinary record, 172(20), 527-527 (2013-03-07) Cladribine in the treatment of acute myeloid leukemia.Tadeusz Robak et al.Leukemia research, 38(4), 425-427 (2014-02-04) The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.Lili Xiang et al.Annals of hematology, 92(8), 1063-1069 (2013-03-22) Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.Cui-Zan Cai et al.Phytomedicine : international journal of phytotherapy and phytopharmacology, 61, 152842-152842 (2019-05-03) Prostate carcinoma cell growth-inhibiting hydrogel supports axonal regeneration in vitro.K Franke et al.Neuroscience letters, 541, 248-252 (2013-02-19) Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study.Jorge Cortes et al.The Lancet. Oncology, 14(4), 354-362 (2013-03-05) Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity.Joost J Leenders et al.The Journal of biological chemistry, 285(35), 27449-27456 (2010-06-23) Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo.Min-Tae Jeon et al.British journal of pharmacology, 177(3), 668-686 (2019-10-29) Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience.Wenjuan Yu et al.Annals of hematology, 92(8), 1091-1100 (2013-04-19) Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.Caldwell JT, Edwards H, Buck SA, et al. Pediatric Blood & Cancer, 61(10), 1767-1773 (2014) Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma.Sung Hee Lim et al.Japanese journal of clinical oncology, 43(6), 676-680 (2013-04-09) Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity.Maria S Ioannou et al.Cell, 177(6), 1522-1535 (2019-05-28) Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases.Brianne A Wilton et al.Virology, 374(1), 82-99 (2008-01-29) Holographic two-photon activation for synthetic optogenetics.Ido Carmi et al.Nature protocols, 14(3), 864-900 (2019-02-26) Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.Yi-Bin Chen et al.Cancer, 121(2), 226-233 (2014-09-11) Deletion of calcineurin from GFAP-expressing astrocytes impairs excitability of cerebellar and hippocampal neurons through astroglial Na+ /K+ ATPase.Laura Tapella et al.Glia, 68(3), 543-560 (2019-10-19) Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development.Jinhua Liu et al.Nature communications, 9(1), 4386-4386 (2018-10-24) Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML).Ulf Schnetzke et al.Journal of cancer research and clinical oncology, 140(8), 1391-1397 (2014-04-15) Corneal microcysts.Virinder K Dhillon et al.The British journal of ophthalmology, 98(1), 138-138 (2013-10-08) Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.Michaela Rancea et al.Journal of the National Cancer Institute, 106(8), doi:10-doi:10 (2014-07-18) Diurnal properties of voltage-gated Ca2+ currents in suprachiasmatic nucleus and roles in action potential firing.Beth A McNally et al.The Journal of physiology, 598(9), 1775-1790 (2019-06-10) An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.Yasuhiko Kizuka et al.EMBO molecular medicine, 7(2), 175-189 (2015-01-17) Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients.G Visani et al.Leukemia, 28(4), 967-970 (2014-01-21) Kirrel3-Mediated Synapse Formation Is Attenuated by Disease-Associated Missense Variants.Matthew R Taylor et al.The Journal of neuroscience : the official journal of the Society for Neuroscience, 40(28), 5376-5388 (2020-06-07) Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.Zhiyong Yu et al.Internal medicine (Tokyo, Japan), 52(6), 689-693 (2013-03-19) Involvement of PI3K/Akt/TOR pathway in stretch-induced hypertrophy of myotubes.Nobuaki Sasai et al.Muscle & nerve, 41(1), 100-106 (2009-09-22) [Pseudo-hyperkalemia and hyperleukocytosis].A Goubella et al.Revue medicale de Bruxelles, 34(3), 179-180 (2013-08-21) Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.Cyril Lervat et al.Pediatric blood & cancer, 61(3), 473-478 (2013-08-24) Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage.Annamaria Buschini et al.Occupational and environmental medicine, 70(11), 789-794 (2013-10-22) Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.Arne Kolstad et al.Blood, 123(19), 2953-2959 (2014-03-22) Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.Elias Jabbour et al.American journal of hematology, 89(4), 395-398 (2014-01-01) Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.Sachit A Patel et al.Journal of pediatric hematology/oncology, 36(6), 491-494 (2013-12-11) Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.Sarah A Buckley et al.American journal of hematology, 89(4), 423-428 (2014-01-03) Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.Aziz Nazha et al.American journal of hematology, 88(11), 961-966 (2013-07-24) Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.Celalettin Eroglu et al.American journal of clinical oncology, 38(1), 68-73 (2013-04-09) Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.Koji Kato et al.Pediatric blood & cancer, 61(4), 712-716 (2014-01-01) Nicotine Modulates Mitochondrial Dynamics in Hippocampal Neurons.Juan A Godoy et al.Molecular neurobiology, 55(12), 8965-8977 (2018-04-06) Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.Yuki Kojima et al.Japanese journal of clinical oncology, 44(4), 318-323 (2014-02-22) A novel bioluminescent bacterial biosensor for measurement of Ara-CTP and cytarabine potentiation by fludarabine in seven leukaemic cell lines.Elizabeth Anderson et al.Leukemia research, 37(6), 690-696 (2013-03-12) Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia.Hagop M Kantarjian et al.Cancer, 119(14), 2611-2619 (2013-04-23) Myosin VI Drives Clathrin-Mediated AMPA Receptor Endocytosis to Facilitate Cerebellar Long-Term Depression.Wolfgang Wagner et al.Cell reports, 28(1), 11-20 (2019-07-04) Chemical genetics reveals a complex functional ground state of neural stem cells.Phedias Diamandis et al.Nature chemical biology, 3(5), 268-273 (2007-04-10) GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis.Qiang Xiao et al.Annals of hematology, 93(8), 1381-1390 (2014-07-06) Knockdown of CD44 enhances chemosensitivity of acute myeloid leukemia cells to ADM and Ara-C.Ni-sha Wang et al.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(4), 3933-3940 (2014-01-01) Cessation of electrically-induced muscle contraction activates autophagy in cultured myotubes.Kiyoshi Yoshioka et al.Biochemical and biophysical research communications, 533(3), 410-416 (2020-09-26) DYNLRB1 is essential for dynein mediated transport and neuronal survival.Marco Terenzio et al.Neurobiology of disease, 140, 104816-104816 (2020-02-24) Live-cell imaging of autophagy induction and autophagosome-lysosome fusion in primary cultured neurons.Mona Bains et al.Methods in enzymology, 453, 145-158 (2009-02-17) Post-chemotherapeutic resolution of acute myeloid leukaemia-induced gingival enlargement: a case report.S Singh-Rambiritch et al.SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 67(7), 344-347 (2013-08-21) Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.Ajay Vora et al.The Lancet. Oncology, 15(8), 809-818 (2014-06-14) Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.Sylvain Pilorge et al.American journal of hematology, 89(4), 399-403 (2014-01-01) The DNA damage response induces antigen presenting cell-like functions in fibroblasts.Melissa Li Fang Tang et al.European journal of immunology, 44(4), 1108-1118 (2014-01-01) Purification and culture of nerve growth factor receptor (p75)-expressing basal forebrain cholinergic neurons.Aletta C Schnitzler et al.Nature protocols, 3(1), 34-40 (2008-01-15) Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability.Yuliya Voskobiynyk et al.eLife, 9 (2020-07-14) Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.Yuki Kojima et al.Japanese journal of clinical oncology, 44(4), 318-323 (2014-02-22) Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia.F Ravandi et al.Leukemia, 28(7), 1543-1545 (2014-02-04) Sensitivity of the polymerase of vesicular stomatitis virus to 2' substitutions in the template and nucleotide triphosphate during initiation and elongation.Benjamin Morin et al.The Journal of biological chemistry, 289(14), 9961-9969 (2014-02-15) The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia.Carlo Visco et al.American journal of hematology, 88(4), 289-293 (2013-03-02) Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.Matthew J Ehrhardt et al.Journal of pediatric hematology/oncology, 37(1), e37-e40 (2013-12-11) High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.Noortje Thielen et al.Annals of hematology, 92(8), 1049-1056 (2013-04-11) Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia.Yi-Yang Chen et al.Annals of hematology, 93(8), 1441-1442 (2013-12-18) A novel acidic serine protease, ASPNJ inhibits proliferation, induces apoptosis and enhances chemo-susceptibility of acute promyelocytic leukemia cell.Xin Ge et al.Leukemia research, 37(12), 1697-1703 (2013-10-31) DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.Jan-Henrik Mikesch et al.Annals of hematology, 92(8), 1041-1048 (2013-03-28) Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.Gautam Borthakur et al.American journal of hematology, 89(10), 964-968 (2014-07-06) Acute myeloid leukemia in first remission: to choose transplantation or not?Richard M Stone Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(10), 1262-1266 (2013-02-27) MicroRNA-210 Downregulates ISCU and Induces Mitochondrial Dysfunction and Neuronal Death in Neonatal Hypoxic-Ischemic Brain Injury.Qingyi Ma et al.Molecular neurobiology, 56(8), 5608-5625 (2019-01-19) Polarization of Reactive Astrocytes in Response to Spinal Cord Injury is Enhanced by M2 Macrophage-Mediated Activation of Wnt/β-Catenin Pathway.Iki Sonn et al.Molecular neurobiology, 57(4), 1847-1862 (2019-12-18) Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.Lida Kalmanti et al.Annals of hematology, 93(1), 71-80 (2013-10-29) Mantle cell lymphoma: evolving management strategies.Elias Campo et al.Blood, 125(1), 48-55 (2014-12-17) Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: a multicenter, randomized control trial in southwest China.Xi Zhang et al.Leukemia research, 37(6), 657-664 (2013-03-30) Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).Michael E Rytting et al.Cancer, 120(23), 3660-3668 (2014-07-22) Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party.Jae-Sook Ahn et al.Acta haematologica, 133(1), 91-97 (2014-08-30) Gingival pain: an unusual side effect of ziprasidone.Ashwati Raghunath BMJ case reports, 2013, doi:10-doi:10 (2013-01-04) Fatal cisplatin overdose in the treatment of mediastinal lymphoma with the ESHAP regimen - analysis of the causes of the adverse drug event.Tomasz Jurek et al.Onkologie, 36(1-2), 49-52 (2013-02-23) NMMHC IIA triggers neuronal autophagic cell death by promoting F-actin-dependent ATG9A trafficking in cerebral ischemia/reperfusion.Guangyun Wang et al.Cell death & disease, 11(6), 428-428 (2020-06-10) Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis.C Samarawickrama et al.Leukemia, 28(1), 220-222 (2013-08-14) An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.Hong Wang et al.International journal of cancer, 135(12), 2783-2794 (2014-04-23) Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.Takahiro Yamauchi et al.Anticancer research, 34(4), 1657-1662 (2014-04-03) Decitabine. Acute myeloid leukaemia: no progress. Prescrire international, 23(148), 92-94 (2014-05-27) Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial.Julie M Vose et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(13), 1662-1668 (2013-03-13) Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.Jorge E Cortes et al.Cancer, 121(2), 234-242 (2014-09-17) The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.Hiba Ahmad Zahreddine et al.Nature, 511(7507), 90-93 (2014-05-30) Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).Sergio Amadori et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(35), 4424-4430 (2013-10-16) Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.Elias Jabbour et al.American journal of hematology, 89(4), 395-398 (2014-01-01) Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia.Hagop M Kantarjian et al.Cancer, 119(14), 2611-2619 (2013-04-23) Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.Sachit A Patel et al.Journal of pediatric hematology/oncology, 36(6), 491-494 (2013-12-11) Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.Sarah A Buckley et al.American journal of hematology, 89(4), 423-428 (2014-01-03) Myosin VI Drives Clathrin-Mediated AMPA Receptor Endocytosis to Facilitate Cerebellar Long-Term Depression.Wolfgang Wagner et al.Cell reports, 28(1), 11-20 (2019-07-04) A novel bioluminescent bacterial biosensor for measurement of Ara-CTP and cytarabine potentiation by fludarabine in seven leukaemic cell lines.Elizabeth Anderson et al.Leukemia research, 37(6), 690-696 (2013-03-12) Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.Aziz Nazha et al.American journal of hematology, 88(11), 961-966 (2013-07-24) Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.Arne Kolstad et al.Blood, 123(19), 2953-2959 (2014-03-22) Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.Koji Kato et al.Pediatric blood & cancer, 61(4), 712-716 (2014-01-01) Regenerating cortical connections in a dish: the entorhino-hippocampal organotypic slice co-culture as tool for pharmacological screening of molecules promoting axon regeneration.José Antonio del Río et al.Nature protocols, 5(2), 217-226 (2010-02-06) When the eye gives it all: diagnosis of relapsing acute myeloblastic leukemia with anterior chamber tap of a chronic hypopyon.Valerie Touitou et al.American journal of hematology, 89(8), 858-859 (2014-08-29) Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.Vindhya Vijay et al.Leukemia research, 84, 106180-106180 (2019-07-13) Multiple myeloma: a descriptive study of 217 Egyptian patients.Noha M El Husseiny et al.Annals of hematology, 93(1), 141-145 (2013-07-31) A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.Kenneth F Bradstock et al.British journal of haematology, 167(5), 618-625 (2014-08-22) Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.Enrico De Astis et al.Annals of hematology, 93(12), 2011-2018 (2014-07-06) L-type Ca2+ channel-mediated Ca2+ influx adjusts neuronal mitochondrial function to physiological and pathophysiological conditions.Matej Hotka et al.Science signaling, 13(618) (2020-02-13) Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.Li Gao et al.Leukemia research, 37(11), 1482-1487 (2013-09-24) Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.Paul J Galardy et al.British journal of haematology, 163(3), 365-372 (2013-09-17) A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity.Travis Rush et al.Neurobiology of disease, 134, 104668-104668 (2019-11-08) Glial cell line-derived neurotrophic factor promotes increased phenotypic marker expression in femoral sensory and motor-derived Schwann cell cultures.Nithya J Jesuraj et al.Experimental neurology, 257, 10-18 (2014-04-16) SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.Anjali S Advani et al.British journal of haematology, 167(2), 233-237 (2014-07-22) Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.Daniel Nowak et al.Experimental hematology, 43(1), 32-43 (2014-12-03) Multiple myeloma: a descriptive study of 217 Egyptian patients.Noha M El Husseiny et al.Annals of hematology, 93(1), 141-145 (2013-07-31) Regenerating cortical connections in a dish: the entorhino-hippocampal organotypic slice co-culture as tool for pharmacological screening of molecules promoting axon regeneration.José Antonio del Río et al.Nature protocols, 5(2), 217-226 (2010-02-06) When the eye gives it all: diagnosis of relapsing acute myeloblastic leukemia with anterior chamber tap of a chronic hypopyon.Valerie Touitou et al.American journal of hematology, 89(8), 858-859 (2014-08-29) Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.Vindhya Vijay et al.Leukemia research, 84, 106180-106180 (2019-07-13) Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier.Steinunn Sara Helgudottir et al.Molecular neurobiology, 57(8), 3526-3539 (2020-06-17) Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia.Michaela Liedtke et al.Leukemia research, 38(12), 1441-1445 (2014-12-03) A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.Terzah M Horton et al.Pediatric blood & cancer, 61(10), 1754-1760 (2014-07-01) Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.Cheng-Han Wu et al.Annals of hematology, 93(6), 1079-1081 (2013-10-31)

备注